These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 16454975

  • 1. XS0601 reduces the incidence of restenosis: a prospective study of 335 patients undergoing percutaneous coronary intervention in China.
    Chen KJ, Shi DZ, Xu H, Lü SZ, Li TC, Ke YN, Zhang MZ, Lu XY, Sun RY, You SJ.
    Chin Med J (Engl); 2006 Jan 05; 119(1):6-13. PubMed ID: 16454975
    [Abstract] [Full Text] [Related]

  • 2. A multi-center randomized double-blind placebo-controlled trial of Xiongshao Capsule in preventing restenosis after percutaneous coronary intervention: a subgroup analysis of senile patients.
    Shang QH, Xu H, Lu XY, Wen C, Shi DZ, Chen KJ.
    Chin J Integr Med; 2011 Sep 05; 17(9):669-74. PubMed ID: 21910067
    [Abstract] [Full Text] [Related]

  • 3. A comparison of clinical and angiographic outcomes after Excel bioabsorbable polymer versus Firebird durable polymer rapamycin-eluting stent for the treatment of coronary artery disease in a "real world" setting: six-month follow-up results.
    Liu HB, Xu B, Qiao SB, Yang YJ, Ma WH, Qin XW, Yao M, Wu YJ, Yuan JQ, Chen J, You SJ, Dai J, Xia R, Li JJ, Chen JL, Gao RL.
    Chin Med J (Engl); 2007 Apr 05; 120(7):574-7. PubMed ID: 17442205
    [Abstract] [Full Text] [Related]

  • 4. Beta-blockers reduce the incidence of clinical restenosis: prospective study of 4840 patients undergoing percutaneous coronary revascularization.
    Jackson JD, Muhlestein JB, Bunch TJ, Bair TL, Horne BD, Madsen TE, Lappé JM, Anderson JL, Intermountain Heart Collaborative Study Group.
    Am Heart J; 2003 May 05; 145(5):875-81. PubMed ID: 12766747
    [Abstract] [Full Text] [Related]

  • 5. A randomized, double-blind, placebo-controlled trial on restenosis prevention by the receptor tyrosine kinase inhibitor imatinib.
    Zohlnhöfer D, Hausleiter J, Kastrati A, Mehilli J, Goos C, Schühlen H, Pache J, Pogatsa-Murray G, Heemann U, Dirschinger J, Schömig A.
    J Am Coll Cardiol; 2005 Dec 06; 46(11):1999-2003. PubMed ID: 16325031
    [Abstract] [Full Text] [Related]

  • 6. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.
    Hueb W, Lopes NH, Gersh BJ, Soares P, Machado LA, Jatene FB, Oliveira SA, Ramires JA.
    Circulation; 2007 Mar 06; 115(9):1082-9. PubMed ID: 17339566
    [Abstract] [Full Text] [Related]

  • 7. A randomized trial of the low-molecular-weight heparin certoparin to prevent restenosis following coronary angioplasty.
    Grassman ED, Leya F, Fareed J, Lewis BE, Bacher P, Loeb HS, Moran JF.
    J Invasive Cardiol; 2001 Nov 06; 13(11):723-8. PubMed ID: 11689712
    [Abstract] [Full Text] [Related]

  • 8. Comparison of drug eluting stents with bare metal stents in daily practice for bifurcation lesions in Chinese patients.
    Kang S, Yang YJ, Xu B, Chen JL, Qiao SB, Yao M, Chen J, Wu YJ, Liu HB, Dai J, Yuan JQ, Li JJ, Gao RL.
    Chin Med J (Engl); 2006 Jul 20; 119(14):1157-64. PubMed ID: 16863606
    [Abstract] [Full Text] [Related]

  • 9. First experience with hybrid percutaneous transmyocardial laser revascularization and angioplasty in patients with lesions at high risk for restenosis: Results of a phase I feasibility study.
    Stone GW, St Goar FG, Taussig A, Power JA, Kosinski E, Shawl F.
    Am Heart J; 2001 Oct 20; 142(4):679-83. PubMed ID: 11579359
    [Abstract] [Full Text] [Related]

  • 10. Oral rapamycin after coronary bare-metal stent implantation to prevent restenosis: the Prospective, Randomized Oral Rapamycin in Argentina (ORAR II) Study.
    Rodriguez AE, Granada JF, Rodriguez-Alemparte M, Vigo CF, Delgado J, Fernandez-Pereira C, Pocovi A, Rodriguez-Granillo AM, Schulz D, Raizner AE, Palacios I, O'Neill W, Kaluza GL, Stone G, ORAR II Investigators.
    J Am Coll Cardiol; 2006 Apr 18; 47(8):1522-9. PubMed ID: 16630986
    [Abstract] [Full Text] [Related]

  • 11. Six-month outcomes after single- and multi-lesion percutaneous coronary intervention: results from the ROSETTA registry.
    Goldman LE, Okrainec K, Eisenberg MJ, Schechter D, Lefkovits J, Goudreau E, Deligonul U, Mak KH, Del Core M, Duerr R, Huynh T, Smilovitch M, Sedlis S, Brown DL, Brieger D, ROSETTA Investigators.
    Can J Cardiol; 2004 May 01; 20(6):608-12. PubMed ID: 15152290
    [Abstract] [Full Text] [Related]

  • 12. Outcome of patients with prior percutaneous revascularization undergoing repeat coronary intervention (from the PRESTO Trial).
    Arjomand H, Willerson JT, Holmes DR, Bamlet WR, Surabhi SK, Roukoz B, Espinoza A, McClelland RL, McCormick DJ, Goldberg S, PRESTO Investigators.
    Am J Cardiol; 2005 Sep 15; 96(6):741-6. PubMed ID: 16169350
    [Abstract] [Full Text] [Related]

  • 13. Coronary artery bypass surgery versus percutaneous coronary intervention with drug-eluting stent implantation in patients with multivessel coronary disease.
    Yang ZK, Shen WF, Zhang RY, Kong Y, Zhang JS, Hu J, Zhang Q, Ding FH.
    J Interv Cardiol; 2007 Feb 15; 20(1):10-6. PubMed ID: 17300391
    [Abstract] [Full Text] [Related]

  • 14. Effects of high-dose statin administered prior to coronary angioplasty on the incidence of cardiac events in patients with acute coronary syndrome.
    Chyrchel M, Rakowski T, Rzeszutko L, Legutko J, Dziewierz A, Dubiel JS, Dudek D.
    Kardiol Pol; 2006 Dec 15; 64(12):1357-62; discussion 1363. PubMed ID: 17206539
    [Abstract] [Full Text] [Related]

  • 15. Drug-eluting stent-supported percutaneous coronary intervention for chronic total coronary occlusion.
    Migliorini A, Moschi G, Vergara R, Parodi G, Carrabba N, Antoniucci D.
    Catheter Cardiovasc Interv; 2006 Mar 15; 67(3):344-8. PubMed ID: 16489559
    [Abstract] [Full Text] [Related]

  • 16. Decreased rate of coronary restenosis after lowering of plasma homocysteine levels.
    Schnyder G, Roffi M, Pin R, Flammer Y, Lange H, Eberli FR, Meier B, Turi ZG, Hess OM.
    N Engl J Med; 2001 Nov 29; 345(22):1593-600. PubMed ID: 11757505
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of stenting for unprotected left main coronary artery disease in 297 patients.
    Han YL, Wang SL, Jin QM, Liu HW, Ma YY, Wang ZL, Wang DM, Luan B, Wang G.
    Chin Med J (Engl); 2006 Apr 05; 119(7):544-50. PubMed ID: 16620694
    [Abstract] [Full Text] [Related]

  • 18. Acute coronary syndrome may occur with in-stent restenosis and is associated with adverse outcomes (the PRESTO trial).
    Assali AR, Moustapha A, Sdringola S, Denktas AE, Willerson JT, Holmes DR, Smalling RW.
    Am J Cardiol; 2006 Sep 15; 98(6):729-33. PubMed ID: 16950172
    [Abstract] [Full Text] [Related]

  • 19. Safety of sirolimus-eluting stenting and its effect on restenosis in patients with unstable angina pectoris (a SIRIUS substudy).
    Weisz G, Moses JW, Teirstein PS, Holmes DR, Raizner AE, Satler LF, Mishkel G, Wilensky RL, Wang P, Kuntz RE, Popma JJ, Leon MB.
    Am J Cardiol; 2007 Apr 15; 99(8):1044-50. PubMed ID: 17437725
    [Abstract] [Full Text] [Related]

  • 20. Nitroglycerin infusion after percutaneous coronary intervention does not influence short- and long-term outcome--a prospective NAPI (Nitroglycerin Administration after Percutaneous Intervention) study.
    Foryś J, Peruga J, Plewka M, Lipiec P, Jasińska A, Krzemińska-Pakuła M, Kasprzak J.
    Kardiol Pol; 2007 Jul 15; 65(7):789-803; discussion 804-5. PubMed ID: 17694461
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.